Radial Artery Occlusion
Conditions
Brief summary
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.
Interventions
Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization
Sponsors
Study design
Eligibility
Inclusion criteria
* Any patient referred for a diagnostic transradial catheterism
Exclusion criteria
* Unable to understand study design or provide informed consent * Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine * Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access. * Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rates of patent hemostasis | within 24 hours after diagnostic angiography | Evaluation of patent hemostasis by pulse oximetry |
| Time to hemostasis | within 24 hours post-procedure | — |
| Nursing time involvement | within 24 hours post-procedure | Calculation of nursing time required for surveillance and care of hemostasis |
| Evaluation of complications | within 30 days of procedure | Compilation of access site complications such as radial artery occlusion, bleeding, presence and grading of hematomas, etc. |
Countries
Canada